All Stories

  1. Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma

    Article • International Journal of Nanomedicine, October 2019, Taylor & Francis

    eman Alaaeldin, Professor Hatem A Sarhan, Dr Bakheet Elsadek , Shady Allam, Mahmoud Elsayed, Ahmed Ahmed

  2. Validation of the Diagnostic and Prognostic Values of ADAMTS5 and FSTL1 in Osteoarthritis Rat Model

    Article • Cartilage, June 2019, SAGE Publications

    Dr Bakheet Elsadek

  3. Lesional and circulating levels of interleukin-17 and 25-hydroxycholecalciferol in active acne vulgaris: Correlation to disease severity

    Article • Journal of Cosmetic Dermatology, August 2018, Wiley

    Dr Bakheet Elsadek

  4. Expression profiles of TRPV1, TRPV4, TLR4 and ERK1/2 in the dorsal root ganglionic neurons of a cancer-induced neuropathy rat model

    Article • PeerJ, April 2018, PeerJ

    Dr Bakheet Elsadek

  5. Development and optimization of a novel drug free nanolipid vesicular system for treatment of osteoarthritis

    Article • Drug Development and Industrial Pharmacy, December 2017, Taylor & Francis

    Dr Bakheet Elsadek

  6. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model

    Article • Canadian Journal of Physiology and Pharmacology, December 2017, Canadian Science Publishing

    Dr Bakheet Elsadek

  7. Design, synthesis, docking studies and biological evaluation of novel chalcone derivatives as potential histone deacetylase inhibitors

    Article • Bioorganic Chemistry, June 2017, Elsevier

    Dr Bakheet Elsadek

  8. The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib

    Article • Digestive and Liver Disease, February 2017, Elsevier

    Dr Bakheet Elsadek

  9. Design, synthesis and pharmacophoric model building of new 3-alkoxymethyl/3-phenyl indole-2-carboxamides with potential antiproliferative activity

    Article • Chemical Biology & Drug Design, January 2017, Wiley

    Dr Bakheet Elsadek , Dr bahaa G. M. Youssif

  10. Zinc oxide nanoparticles as a novel anticancer approach; in vitro and in vivo evidence

    Article • Clinical and Experimental Pharmacology and Physiology, January 2017, Wiley

    Dr Bakheet Elsadek

  11. Circulating Survivin and TIMP-1 in Hepatitis C Virus Associated Liver Fibrosis

    Article • International Journal of Biochemistry Research & Review, January 2017, Sciencedomain International

    Dr Bakheet Elsadek

  12. A Novel Model of Cancer-Induced Peripheral Neuropathy and the Role of TRPA1 in Pain Transduction

    Article • Pain Research and Management, January 2017, Hindawi Publishing Corporation

    Dr Bakheet Elsadek

  13. Survivin as a Novel Biomarker in the Pathogenesis of Acne Vulgaris and Its Correlation to Insulin-Like Growth Factor-I

    Article • Disease Markers, January 2016, Hindawi Publishing Corporation

    Dr Bakheet Elsadek

  14. Priority of Alpha-L- Fucosidase Over Alpha fetoprotein in Early Detection of Hepatocellular Carcinoma in Animals and Human

    Article • Acta Oncologica Turcica, January 2014, LookUs Bilisim, Ltd.

    Dr Bakheet Elsadek

  15. Clinical impact of serum proteins on drug delivery

    Article • Journal of Controlled Release, July 2012, Elsevier

    Dr Bakheet Elsadek

  16. Impact of albumin on drug delivery — New applications on the horizon

    Article • Journal of Controlled Release, January 2012, Elsevier

    Dr Bakheet Elsadek

  17. Serum Proteins as Drug Carriers of Anticancer Agents

    Article • December 2011, Wiley

    Dr Bakheet Elsadek

  18. Implication of Umbilical Cord in Preeclampsia

    Article • Medical Principles and Practice, January 2011, Karger Publishers

    Dr Bakheet Elsadek

  19. Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: An in vitro and in vivo evaluation study

    Article • European Journal of Cancer, December 2010, Elsevier

    Dr Bakheet Elsadek

  20. In vivo evaluation of a novel albumin-binding prodrug of doxorubicin in an orthotopic mouse model of prostate cancer (LNCaP)

    Article • Prostate Cancer and Prostatic Diseases, November 2010, Springer Science + Business Media

    Dr Bakheet Elsadek

  21. Optimization of an Albumin-Binding Prodrug of Doxorubicin That Is Cleaved by Prostate-Specific Antigen

    Article • ACS Medicinal Chemistry Letters, May 2010, American Chemical Society (ACS)

    Dr Bakheet Elsadek

  22. Abstract LB-38: Evaluation of a PSA cleavable doxorubicin prodrug in thein vitroandin vivoLNCaP LN model

    Article • Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Dr Bakheet Elsadek

  23. Abstract LB-39: Development of a novel water-soluble prodrug of paclitaxel that is cleaved by prostate-specific antigen (PSA):In vitroandin vivoevaluation

    Article • Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Dr Bakheet Elsadek